Asteria Health Recalls Testosterone and Triamcinolone Acetonide Pellets Due to Potential Metal Contamination
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
F.H. INVESTMENTS, Inc. (dba Asteria Health) is recalling 7,840 sterile pellets after discovering the potential presence of metal particulate matter.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drugs.
What Happened
F.H. INVESTMENTS, Inc., doing business as Asteria Health, has initiated a voluntary recall of specific sterile pellets. The recall was issued due to the potential presence of a foreign substance, specifically metal particulate matter, within the product. The FDA has classified this as a Class II recall.
Which Products Are Affected
The recall involves 7,840 units of Testosterone 200mg and Triamcinolone Acetonide 40mcg sterile pellets.
- Product Name: Testosterone 200mg, Triamcinolone Acetonide 40mcg, 1 Sterile Pellet
- Brand/Label: Asteria Health (432 Industrial Ln, Birmingham, AL 35211)
- NDC: 79559-6200-43
- Lot Number: 256000105
- Expiration Date: 09/19/2026
- Recall Number: D-0329-2026
These products were distributed nationwide across the United States.
What You Should Do
Consumers and healthcare providers should immediately stop using the affected lot. The firm initiated the recall via notification letters. For further information regarding returns or specific instructions, stakeholders should contact F.H. INVESTMENTS, Inc. (dba Asteria Health) at their Birmingham, Alabama facility.
Why This Matters
The presence of metal particulate matter in a sterile product intended for medical use poses a risk of adverse health consequences, including potential injury or inflammation at the site of administration.
Source
This information is based on official recall data provided by the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.